Feng Xin, Ye Xingyou, Park Jun-Bom, Lu Wenli, Morott Joe, Beissner Brad, Lian Zhuoyang John, Pinto Elanor, Bi Vivian, Porter Stu, Durig Tom, Majumdar Soumyajit, Repka Michael A
a Department of Pharmaceutics and Drug Delivery, School of Pharmacy , The University of Mississippi , Mississippi , MS , USA .
Drug Dev Ind Pharm. 2015;41(9):1479-87. doi: 10.3109/03639045.2014.958755. Epub 2015 Jul 21.
The recrystallization of an amorphous drug in a solid dispersion system could lead to a loss in the drug solubility and bioavailability. The primary objective of the current research was to use an improved kinetic model to evaluate the recrystallization kinetics of amorphous structures and to further understand the factors influencing the physical stability of amorphous solid dispersions. Amorphous solid dispersions of fenofibrate with different molecular weights of hydroxypropylcellulose, HPC (Klucel™ LF, EF, ELF) were prepared utilizing hot-melt extrusion technology. Differential scanning calorimetry was utilized to quantitatively analyze the extent of recrystallization in the samples stored at different temperatures and relative humidity (RH) conditions. The experimental data were fitted into the improved kinetics model of a modified Avrami equation to calculate the recrystallization rate constants. Klucel LF, the largest molecular weight among the HPCs used, demonstrated the greatest inhibition of fenofibrate recrystallization. Additionally, the recrystallization rate (k) decreased with increasing polymer content, however exponentially increased with higher temperature. Also k increased linearly rather than exponentially over the range of RH studied.
在固体分散体系中,无定形药物的重结晶可能导致药物溶解度和生物利用度的损失。当前研究的主要目的是使用改进的动力学模型来评估无定形结构的重结晶动力学,并进一步了解影响无定形固体分散体物理稳定性的因素。利用热熔挤出技术制备了非诺贝特与不同分子量羟丙基纤维素(HPC,Klucel™ LF、EF、ELF)的无定形固体分散体。采用差示扫描量热法对在不同温度和相对湿度(RH)条件下储存的样品中的重结晶程度进行定量分析。将实验数据拟合到修正的阿弗拉米方程的改进动力学模型中,以计算重结晶速率常数。在所使用的HPC中分子量最大的Klucel LF对非诺贝特重结晶的抑制作用最大。此外,重结晶速率(k)随着聚合物含量的增加而降低,但随着温度升高呈指数增加。在所研究的RH范围内,k呈线性增加而非指数增加。